Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 04 12:28PM ET
23.43
Dollar change
+0.11
Percentage change
0.47
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y21.71% Shs Outstand Perf Week-1.14%
SponsorInvesco ETF Type Tagsequity Return% 3Y-2.12% Total Holdings215 Perf Month-1.55%
Fund Family Bond Type Tagsbiotechnology Return% 5Y- AUM36.65M Perf Quarter2.67%
IndexNASDAQ Biotechnology Index Average Maturity Tags- Return% 10Y NAV% Perf Half Y9.38%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year20.46%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range18.18 - 24.84 Perf YTD7.04%
Dividend TTM0.24 (1.01%) ESG Type Tags- Flows% 3M6.93% 52W High-5.68% Beta0.68
Dividend Ex-DateSep 23, 2024 Dividend Type Sector/Theme Flows% YTD68.30% 52W Low28.88% ATR (14)0.31
Expense0.19% Structure Type Region Flows% 1Y RSI (14)40.17 Volatility0.96% 1.23%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.26 Prev Close23.32
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume30.76K Price23.43
SMA20-2.28% SMA50-2.21% SMA2003.67% Trades Volume4,190 Change0.47%
Invesco Nasdaq Biotechnology ETF seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index . The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.